pravastatin has been researched along with Hypertrophy, Left Ventricular in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, Y; Rashid, M; Seto, M; Shimokawa, H; Tawara, S; Yano, K | 1 |
| Kassan, M; Montero, MJ; Sevilla, MA | 1 |
| Cadnapaphornchai, MA; George, DM; Masoumi, A; McFann, K; Schrier, RW; Strain, JD | 1 |
| Buckley, B; Ford, I; Jukema, JW; Macfarlane, PW; Murray, H; Sattar, N; Shepherd, J; Stott, DJ; Westendorp, RG | 1 |
| Abouelnaga, ZA; Alhaj, MA; Awad, MM; Citro, LA; El-Sayed, O; Elnakish, MT; Hassanain, HH; Hassona, MD; Khan, M; Kulkarni, A; Kuppusamy, P; Moldovan, L; Sayyid, M | 1 |
| Chou, TF; Lee, TM; Tsai, CH | 1 |
| Liebson, PR | 1 |
| Chang, NC; Chou, TF; Lee, TM; Lin, MS; Tsai, CH | 2 |
| Ichihara, G; Ichihara, S; Kawanishi, S; Nagata, K; Noda, A; Obata, K; Oikawa, S; Xu, J; Yamada, Y; Yokota, M | 1 |
| Chang, NC; Chou, TF; Lee, TM; Lin, MS | 1 |
| Chang, NC; Lee, TM; Lin, MS; Tsai, CH | 1 |
| Akino, M; Matsui, Y; Okamoto, H; Onozuka, H; Tsutsui, H; Xu, Z | 1 |
4 trial(s) available for pravastatin and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Cross-Over Studies; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Leukocytes; Male; Pravastatin; Pyrroles; Quinolines; rac1 GTP-Binding Protein; ras Proteins; Rats; Rats, Inbred WKY; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2009 |
Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.
Topics: Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Kidney; Lisinopril; Male; Polycystic Kidney, Autosomal Dominant; Pravastatin; Renin-Angiotensin System; Young Adult | 2011 |
Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation.
Topics: Anticholesteremic Agents; Blood Pressure; Dinoprost; Echocardiography; F2-Isoprostanes; Female; Humans; Hypercholesterolemia; Hypertrophy, Left Ventricular; Male; Middle Aged; Pravastatin | 2002 |
LIFE and ARBITER.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Atorvastatin; Carotid Artery Diseases; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Losartan; Pravastatin; Pyrroles; Treatment Outcome | 2003 |
9 other study(ies) available for pravastatin and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Male; Nitric Oxide; Nitroprusside; Oxidative Stress; Phenylephrine; Pravastatin; Rats; Rats, Inbred SHR; Superoxides | 2009 |
The incidence and risk factors for new onset atrial fibrillation in the PROSPER study.
Topics: Age Distribution; Aged; Aged, 80 and over; Atrial Fibrillation; Electrocardiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Incidence; Male; Pravastatin; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Risk Reduction Behavior | 2011 |
Cardiac remodeling caused by transgenic overexpression of a corn Rac gene.
Topics: Aging; Amino Acid Sequence; Analysis of Variance; Animals; Echocardiography; Genotype; Hypertrophy, Left Ventricular; Integrin alpha1; Integrin beta1; Magnetic Resonance Imaging; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Myocardium; Myosin Heavy Chains; Phenotype; Plant Proteins; Pravastatin; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Superoxides; Thyroxine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Effect of pravastatin on left ventricular mass by activation of myocardial K ATP channels in hypercholesterolemic rabbits.
Topics: Adenosine Triphosphate; Animals; Anticholesteremic Agents; Disease Models, Animal; Heart; Hypercholesterolemia; Hypertrophy, Left Ventricular; Male; Potassium Channels; Pravastatin; Rabbits | 2004 |
Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Body Weight; Cardiac Pacing, Artificial; Endothelin-1; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Organ Size; Pravastatin; Rats; Rats, Inbred SHR; RNA, Messenger; Ventricular Function | 2005 |
Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Topics: Animals; Anticholesteremic Agents; Atrial Natriuretic Factor; Collagen; Disease Progression; Fibronectins; Glutathione; Heart Failure; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Models, Animal; Myocardium; Myosin Heavy Chains; NADPH Oxidases; Natriuretic Peptide, Brain; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Chloride, Dietary; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2006 |
Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Pravastatin; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Ventricular Remodeling | 2006 |
Effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Echocardiography; Gene Expression Regulation; Glyburide; Heart Ventricles; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Nicorandil; Potassium Channels; Pravastatin; Rats; Rats, Wistar; Vasodilator Agents | 2006 |
Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure, Diastolic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Pravastatin; rho-Associated Kinases; Ventricular Remodeling | 2008 |